Tags

Type your tag names separated by a space and hit enter

Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis.
Benef Microbes. 2017 Oct 13; 8(5):833-840.BM

Abstract

Lactobacillus plantarum IS-10506 is a novel probiotic isolated from dadih, an Indonesian traditional fermented buffalo milk. It's in vitro and in vivo probiotic properties have been assessed. Probiotic function has been shown in vivo by the suppression of allergic reactions in BALB/c mice through the action of T-regulatory cells cytokines by balancing Th1 and Th2 immune response. Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease characterised by the imbalance of Th1 and Th2. The aim of the study was to assess the probiotic function of L. plantarum IS-10506 in children with mild and moderate AD. A randomised double-blind placebo-controlled trial comparing microencapsulated L. plantarum IS-10506 (1010 cfu/day) and placebo (skim milk-Avicel) twice daily for 12 weeks was conducted in an outpatient clinic on children with mild and moderate AD. The trial included 22 AD children divided into intervention and control groups of n=12 and n=10 patients, respectively. Scoring Atopic Dermatitis Index (SCORAD) and serum immunoglobulin E (IgE), interleukin (IL)-4, interferon gamma (IFN-γ), forkhead box P3 (Foxp3+)/IL-10, and IL-17 levels were assessed. Demographic and baseline characteristics were not significantly different between the two groups. SCORAD and levels of IL-4, IFN-γ, and IL-17 were significantly lower in the probiotic group than those in the placebo group, while the IgE levels were not significantly changed. The ratio of Foxp3+ to IL-10 was significantly higher in the probiotic group than that in placebo group. Supplementation with the probiotic L. plantarum IS-10506 offered a potential treatment for children with AD. Further long-term studies with a larger sample size are required to confirm the therapeutic efficacy of L. plantarum IS-10506 in AD.

Authors+Show Affiliations

1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.1 Dermatology and Venereology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Prof Dr. Moestopo No.47, 60131 Surabaya, East Java, Indonesia.2 Clinical Pathology Department, Faculty of Medicine, Universitas Airlangga, Dr Soetomo Teaching Hospital, Surabaya, East Java, Indonesia.3 Food Technology Department, Faculty of Engineering, Bina Nusantara University, Alam Sutera, Serpong, Tangerang, Indonesia.

Pub Type(s)

Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

29022387

Citation

Prakoeswa, C R S., et al. "Lactobacillus Plantarum IS-10506 Supplementation Reduced SCORAD in Children With Atopic Dermatitis." Beneficial Microbes, vol. 8, no. 5, 2017, pp. 833-840.
Prakoeswa CRS, Herwanto N, Prameswari R, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes. 2017;8(5):833-840.
Prakoeswa, C. R. S., Herwanto, N., Prameswari, R., Astari, L., Sawitri, S., Hidayati, A. N., Indramaya, D. M., Kusumowidagdo, E. R., & Surono, I. S. (2017). Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Beneficial Microbes, 8(5), 833-840. https://doi.org/10.3920/BM2017.0011
Prakoeswa CRS, et al. Lactobacillus Plantarum IS-10506 Supplementation Reduced SCORAD in Children With Atopic Dermatitis. Benef Microbes. 2017 Oct 13;8(5):833-840. PubMed PMID: 29022387.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. AU - Prakoeswa,C R S, AU - Herwanto,N, AU - Prameswari,R, AU - Astari,L, AU - Sawitri,S, AU - Hidayati,A N, AU - Indramaya,D M, AU - Kusumowidagdo,E R, AU - Surono,I S, Y1 - 2017/10/12/ PY - 2017/10/13/pubmed PY - 2018/5/31/medline PY - 2017/10/13/entrez KW - Lactobacillus plantarum IS-10506 KW - SCORAD KW - atopic dermatitis KW - children KW - probiotic SP - 833 EP - 840 JF - Beneficial microbes JO - Benef Microbes VL - 8 IS - 5 N2 - Lactobacillus plantarum IS-10506 is a novel probiotic isolated from dadih, an Indonesian traditional fermented buffalo milk. It's in vitro and in vivo probiotic properties have been assessed. Probiotic function has been shown in vivo by the suppression of allergic reactions in BALB/c mice through the action of T-regulatory cells cytokines by balancing Th1 and Th2 immune response. Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease characterised by the imbalance of Th1 and Th2. The aim of the study was to assess the probiotic function of L. plantarum IS-10506 in children with mild and moderate AD. A randomised double-blind placebo-controlled trial comparing microencapsulated L. plantarum IS-10506 (1010 cfu/day) and placebo (skim milk-Avicel) twice daily for 12 weeks was conducted in an outpatient clinic on children with mild and moderate AD. The trial included 22 AD children divided into intervention and control groups of n=12 and n=10 patients, respectively. Scoring Atopic Dermatitis Index (SCORAD) and serum immunoglobulin E (IgE), interleukin (IL)-4, interferon gamma (IFN-γ), forkhead box P3 (Foxp3+)/IL-10, and IL-17 levels were assessed. Demographic and baseline characteristics were not significantly different between the two groups. SCORAD and levels of IL-4, IFN-γ, and IL-17 were significantly lower in the probiotic group than those in the placebo group, while the IgE levels were not significantly changed. The ratio of Foxp3+ to IL-10 was significantly higher in the probiotic group than that in placebo group. Supplementation with the probiotic L. plantarum IS-10506 offered a potential treatment for children with AD. Further long-term studies with a larger sample size are required to confirm the therapeutic efficacy of L. plantarum IS-10506 in AD. SN - 1876-2891 UR - https://www.unboundmedicine.com/medline/citation/29022387/Lactobacillus_plantarum_IS_10506_supplementation_reduced_SCORAD_in_children_with_atopic_dermatitis_ L2 - http://www.wageningenacademic.com/doi/full/10.3920/BM2017.0011?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -